Aspirin and the risk of cardiovascular events in atherosclerosis patients with and without prior ischemic events.

In this observational analysis of outpatients with stable atherosclerosis, aspirin was marginally beneficial among patients with a prior ischemic event; however, there was no apparent benefit among those with no prior ischemic event.